Advertisement
U.S. Markets closed

IQVIA Holdings Inc. (IQV)

NYSE - Nasdaq Real Time Price. Currency in USD
Visitors trend2W10W9M
201.23-2.79 (-1.37%)
At close: 04:00PM EST
200.59 -0.64 (-0.32%)
After hours: 07:54PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close204.02
Open201.10
Bid191.51 x 800
Ask208.63 x 800
Day's Range198.48 - 202.29
52 Week Range187.62 - 261.73
Volume1,353,505
Avg. Volume1,485,203
Market Cap36.523B
Beta (5Y Monthly)1.51
PE Ratio (TTM)26.44
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • The Wall Street Journal

    A 12-Year-Old’s Journey Into the World of Ozempic

    A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, she decided to have her try semaglutide, the active ingredient in Wegovy and Ozempic.

  • TipRanks

    Iqvia price target lowered to $265 from $280 at Morgan Stanley

    Morgan Stanley lowered the firm’s price target on Iqvia (IQV) to $265 from $280 and keeps an Overweight rating on the shares. A “modest beat” in Q3 was led by better-than-expected TAS performance, but this is overshadowed by R&DS headwinds over the next twelve months, including a single large cancellation and two “mega trial delays” to 2025, the analyst tells investors in a post-earnings note. The firm views the risk/reward as attractive on the recent pullback, the analyst added. Published first